Tag Archives: boston-scientific

Boston Scientific to Participate in Wells Fargo Healthcare Conference

Boston Scientific Corporation is scheduled to participate in the Wells Fargo Healthcare Conference on June 24th in Boston.

  • Share/Bookmark
Posted in News | Also tagged , , , | Comments closed

Boston Scientific Launches Stent

Boston Scientific Corporation recently launched the TAXUS Element Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries.

  • Share/Bookmark
Posted in News | Also tagged , , , , , , , , , | Comments closed

Boston Scientific launches new Taxus stent in EU

Boston Scientific Corp.

  • Share/Bookmark
Posted in News | Also tagged , , , , , , , , | Comments closed

Boston Scientific’s new stent gets first implant in EU

Boston Scientific Corp.s Taxus Element Stent System has launched in the European market and been implanted in its first European patients, the Natick-based medical devices giant announced today.

  • Share/Bookmark
Posted in News | Also tagged , , , , , , , , , , , | Comments closed

Boston Scientific anuncia el lanzamiento en Europa y los primeros implantes del stent de cromo platino TAXUS(R …

Boston Scientific Corporation (NYSE: BSX) ha anunciado hoy el lanzamiento al mercado y el primer implante de su stent coronario liberador de paclitaxel, TAXUS(R) Element(TM) en la Unión Europea y en otros países de aplicación del marcado CE. TAXUS Element constituye la tecnología de tercera generación de la empresa en stents farmacoactivos e incorpora una aleación de cromo-platino junto a un …

  • Share/Bookmark
Posted in News | Also tagged , , , , , , , , | Comments closed

Boston Scientific Gibt Einführung und Erste Implantationen des Platinchrom-Stent-Systems Taxus(R) Element(TM) Bekannt

Boston Scientific Corporation (NYSE: BSX) hat heute die Markteinführung und die ersten Implantationen seines Paclitaxel freisetzenden Koronarstentsystems TAXUS(R) Element(TM) in den Staaten der Europäischen Union sowie weiteren Ländern, in denen die CE-Zertifizierung gilt, bekannt gegeben.

  • Share/Bookmark
Posted in News | Also tagged , , , , , , | Comments closed

Boston Scientific receives CE Mark & US FDA nod for its NC Quantum Apex Balloon Catheter

Boston Scientific Corporation announced CE Mark and US Food and Drug Administration (FDA) approval of its NC Quantum Apex PTCA Dilatation Balloon Catheter. The company plans to launch the product in European markets this week and in the US next month.

  • Share/Bookmark
Posted in News | Also tagged , , , , , , , , | Comments closed

Boston Scientific Begins Trial

Boston Scientific starts clinical trial for Platinum Plus.

  • Share/Bookmark
Posted in News | Also tagged , , | Comments closed

Boston Scientific Begins Platinum Plus Trial for Promus® Element(TM) Stent System

NATICK, Mass., May 26 /PRNewswire-FirstCall/ — Boston Scientific Corporation (NYSE: BSX) today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS(®) Element(TM) Everolimus-Eluting Coronary Stent System to the XIENCE PRIME(TM) Everolimus-Eluting Coronary Stent System.

  • Share/Bookmark
Posted in News | Also tagged , , , , , , , , , , , , , | Comments closed

Boston Scientific Starts Promus Element Stent Vs. Abbott’s Xience Prime Stent Peformance Comparison Trial – Update

Boston Scientific Corp. (BSX) said Wednesday that it has initiated the Platinum Plus clinical trial designed to compare performance of its Promus Element Everolimus-Eluting Coronary Stent System with Abbott Laboratories (ABT) Xience Prime Everolimus-Eluting Coronary Stent System.

  • Share/Bookmark
Posted in News | Also tagged , , , , , , , , , , , , | Comments closed